AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Rifampicin in South Africa
4 products registered with SAHPRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RIFADIN CAPSULES 300 mg | B/20.1.1/3 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 10 Apr 2025 |
| RIFADIN CAPSULES 150 mg | B/20.1.1/2 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 8 Apr 2025 |
| R-CIN SUSPENSION | 32/20.2.3/0371 | ACINO PHARMA (PTY) LTD | suspended | 22 Dec 2023 |
| RIFAGEN 300 mg CAPSULES | R/20.1.1/107 | AfriPharm South Africa (Pty) Ltd | active | 1 Jan 1900 |
Rifampicin — SAHPRA Registration Details
SAHPRA (South Africa) has 4 registered products containing Rifampicin, of which 1 is currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Rifampicin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.